Evaluating the use of hypnosis to reduce anxiety during nuclear medicine exams
Randomized Controlled Study Evaluating the Efficacy of Hypnosis by Deportee Method Adapted to Nuclear Medicine
This study tests if using hypnosis can help reduce anxiety for patients during nuclear medicine exams, making the experience easier for them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Vandoeuvre les Nancy) |
| Trial ID | NCT06116084 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the efficacy of Ericksonian hypnosis in reducing anxiety for patients undergoing nuclear medicine examinations, which often require long periods of immobility. The study aims to implement remote hypnosis techniques using headsets and microphones to minimize the exposure of medical staff to radiation while providing effective anxiety management. Patients will be assessed using the STAI-6 scale to measure anxiety levels before and after the hypnosis intervention. The goal is to improve the quality of imaging examinations and patient compliance.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 80 who are referred for a scan or PET scan and exhibit elevated anxiety levels as indicated by a score greater than 11 on the STAI-6 scale.
Not a fit: Patients with cognitive or auditory impairments, major depressive episodes, or those who have taken anxiolytic medications prior to the examination may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patient comfort and cooperation during nuclear medicine procedures, leading to better diagnostic outcomes.
How similar studies have performed: Previous studies have demonstrated the effectiveness of hypnosis in managing anxiety, suggesting that this approach may yield positive results in the context of nuclear medicine.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient referred for a scan or PET scan * Patient with a score \> 11 on the STAI-6 scale. * Person, speaking and understanding French * Having received complete information on the organization of the research and having signed the informed consent * Age ≥ 18 years, and ≤ 80 years. * Affiliated with a social security plan. Exclusion Criteria: * People who have taken an anxiolytic treatment before going to nuclear medicine. * Persons referred for a neurological examination. * People with cognitive or auditory problems, or with a major depressive episode. * Persons with cardiac rhythm disorders (cardiac arrhythmias) * Persons who cannot perform the examination for which they need a hypnosis session * Women of childbearing age who do not have an effective means of contraception * Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health code (pregnant woman, parturient or nursing mother, adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice, adult person unable to express his consent). * Person deprived of liberty by a judicial or administrative decision, subject to psychiatric care under articles L. 3212-1 and L. 3213-1
Where this trial is running
Vandoeuvre les Nancy
- Nancy Hospital — Vandoeuvre les Nancy, France (Recruiting)
Study contacts
- Principal investigator: Martine Louis — m.louis2@chru-nancy.fr
- Study coordinator: Anne-Sophie Hue
- Email: a.hue@chru-nancy.fr
- Phone: +333153475
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.